Skip to main content
Fig. 4 | Journal of Patient-Reported Outcomes

Fig. 4

From: Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray

Fig. 4

Cumulative distribution function of change from baseline to Day 25 in QLDS score stratified by MADRS change category at Day 25. A, B: Severity Criteria #1; C, D: Severity criteria #2; E, F: Severity Criteria #3 (see Table 1 for details). BL Baseline, IMP Improvement, MADRS Montgomery–Åsberg Depression Rating Scale, QLDS Quality of Life in Depression Scale

Back to article page